ID
25620
Description
Placebo and Active Comparator Controlled Dose Response Study of Rivoglitazone in Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00575874
Link
https://clinicaltrials.gov/show/NCT00575874
Keywords
Versions (1)
- 9/7/17 9/7/17 -
Uploaded on
September 7, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Type 2 Diabetes NCT00575874
Eligibility Type 2 Diabetes NCT00575874
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Diabetes Mellitus, Insulin-Dependent
Data type
boolean
Alias
- UMLS CUI [1]
- C0011854
Description
Ketoacidosis
Data type
boolean
Alias
- UMLS CUI [1]
- C0220982
Description
Insulin regime
Data type
boolean
Alias
- UMLS CUI [1]
- C0557978
Description
C-peptide measurement
Data type
boolean
Alias
- UMLS CUI [1]
- C0202100
Description
Liver Dysfunction
Data type
boolean
Alias
- UMLS CUI [1]
- C0086565
Description
Cardiac Status New York Heart Association Classification | Hospitalization Congestive heart failure | Cardiac ejection fraction
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1999091
- UMLS CUI [1,2]
- C1275491
- UMLS CUI [2,1]
- C0019993
- UMLS CUI [2,2]
- C0018802
- UMLS CUI [3]
- C0232174
Description
Uncontrolled hypertension
Data type
boolean
Alias
- UMLS CUI [1]
- C1868885
Similar models
Eligibility Type 2 Diabetes NCT00575874
- StudyEvent: Eligibility
C1275491 (UMLS CUI [1,2])
C0019993 (UMLS CUI [2,1])
C0018802 (UMLS CUI [2,2])
C0232174 (UMLS CUI [3])